General Information of Drug Off-Target (DOT) (ID: OTUHKKVP)

DOT Name ATP-dependent DNA helicase PIF1 (PIF1)
Synonyms EC 3.6.4.12; DNA repair and recombination helicase PIF1; PIF1/RRM3 DNA helicase-like protein
Gene Name PIF1
Related Disease
Neoplasm ( )
Cerebral palsy ( )
Congestive heart failure ( )
Epileptic encephalopathy ( )
Fatty liver disease ( )
Isolated cleft palate ( )
Prostate cancer ( )
Prostate carcinoma ( )
X-linked Opitz G/BBB syndrome ( )
Hereditary breast carcinoma ( )
Dental caries ( )
UniProt ID
PIF1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
5FHH; 6HPH; 6HPQ; 6HPT; 6HPU
EC Number
3.6.4.12
Pfam ID
PF05970 ; PF21530
Sequence
MLSGIEAAAGEYEDSELRCRVAVEELSPGGQPRRRQALRTAELSLGRNERRELMLRLQAP
GPAGRPRCFPLRAARLFTRFAEAGRSTLRLPAHDTPGAGAVQLLLSDCPPDRLRRFLRTL
RLKLAAAPGPGPASARAQLLGPRPRDFVTISPVQPEERRLRAATRVPDTTLVKRPVEPQA
GAEPSTEAPRWPLPVKRLSLPSTKPQLSEEQAAVLRAVLKGQSIFFTGSAGTGKSYLLKR
ILGSLPPTGTVATASTGVAACHIGGTTLHAFAGIGSGQAPLAQCVALAQRPGVRQGWLNC
QRLVIDEISMVEADLFDKLEAVARAVRQQNKPFGGIQLIICGDFLQLPPVTKGSQPPRFC
FQSKSWKRCVPVTLELTKVWRQADQTFISLLQAVRLGRCSDEVTRQLQATASHKVGRDGI
VATRLCTHQDDVALTNERRLQELPGKVHRFEAMDSNPELASTLDAQCPVSQLLQLKLGAQ
VMLVKNLSVSRGLVNGARGVVVGFEAEGRGLPQVRFLCGVTEVIHADRWTVQATGGQLLS
RQQLPLQLAWAMSIHKSQGMTLDCVEISLGRVFASGQAYVALSRARSLQGLRVLDFDPMA
VRCDPRVLHFYATLRRGRSLSLESPDDDEAASDQENMDPIL
Function
DNA-dependent ATPase and 5'-3' DNA helicase required for the maintenance of both mitochondrial and nuclear genome stability. Efficiently unwinds G-quadruplex (G4) DNA structures and forked RNA-DNA hybrids. Resolves G4 structures, preventing replication pausing and double-strand breaks (DSBs) at G4 motifs. Involved in the maintenance of telomeric DNA. Inhibits telomere elongation, de novo telomere formation and telomere addition to DSBs via catalytic inhibition of telomerase. Reduces the processivity of telomerase by displacing active telomerase from DNA ends. Releases telomerase by unwinding the short telomerase RNA/telomeric DNA hybrid that is the intermediate in the telomerase reaction. Possesses an intrinsic strand annealing activity.
Tissue Specificity Weak ubiquitous expression.
Reactome Pathway
Telomere Extension By Telomerase (R-HSA-171319 )

Molecular Interaction Atlas (MIA) of This DOT

11 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Neoplasm DISZKGEW Definitive Biomarker [1]
Cerebral palsy DIS82ODL Strong Biomarker [2]
Congestive heart failure DIS32MEA Strong Biomarker [3]
Epileptic encephalopathy DISZOCA3 Strong Biomarker [4]
Fatty liver disease DIS485QZ Strong Biomarker [5]
Isolated cleft palate DISV80CD Strong Biomarker [2]
Prostate cancer DISF190Y Strong Biomarker [6]
Prostate carcinoma DISMJPLE Strong Biomarker [6]
X-linked Opitz G/BBB syndrome DISQ14EC Strong Biomarker [4]
Hereditary breast carcinoma DISAEZT5 moderate Biomarker [7]
Dental caries DISRBCMD Limited Biomarker [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
This DOT Affected the Drug Response of 1 Drug(s)
Drug Name Drug ID Highest Status Interaction REF
Gemcitabine DMSE3I7 Approved ATP-dependent DNA helicase PIF1 (PIF1) decreases the response to substance of Gemcitabine. [24]
------------------------------------------------------------------------------------
15 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the expression of ATP-dependent DNA helicase PIF1 (PIF1). [9]
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of ATP-dependent DNA helicase PIF1 (PIF1). [10]
Tretinoin DM49DUI Approved Tretinoin decreases the expression of ATP-dependent DNA helicase PIF1 (PIF1). [11]
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of ATP-dependent DNA helicase PIF1 (PIF1). [12]
Cisplatin DMRHGI9 Approved Cisplatin decreases the expression of ATP-dependent DNA helicase PIF1 (PIF1). [13]
Estradiol DMUNTE3 Approved Estradiol decreases the expression of ATP-dependent DNA helicase PIF1 (PIF1). [14]
Quercetin DM3NC4M Approved Quercetin decreases the expression of ATP-dependent DNA helicase PIF1 (PIF1). [15]
Temozolomide DMKECZD Approved Temozolomide increases the expression of ATP-dependent DNA helicase PIF1 (PIF1). [16]
Calcitriol DM8ZVJ7 Approved Calcitriol decreases the expression of ATP-dependent DNA helicase PIF1 (PIF1). [17]
Testosterone DM7HUNW Approved Testosterone decreases the expression of ATP-dependent DNA helicase PIF1 (PIF1). [17]
Triclosan DMZUR4N Approved Triclosan decreases the expression of ATP-dependent DNA helicase PIF1 (PIF1). [18]
Azathioprine DMMZSXQ Approved Azathioprine decreases the expression of ATP-dependent DNA helicase PIF1 (PIF1). [19]
Leflunomide DMR8ONJ Phase 1 Trial Leflunomide decreases the expression of ATP-dependent DNA helicase PIF1 (PIF1). [21]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 decreases the expression of ATP-dependent DNA helicase PIF1 (PIF1). [22]
Formaldehyde DM7Q6M0 Investigative Formaldehyde decreases the expression of ATP-dependent DNA helicase PIF1 (PIF1). [23]
------------------------------------------------------------------------------------
⏷ Show the Full List of 15 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of ATP-dependent DNA helicase PIF1 (PIF1). [20]
------------------------------------------------------------------------------------

References

1 Human PIF1 helicase supports DNA replication and cell growth under oncogenic-stress.Oncotarget. 2014 Nov 30;5(22):11381-98. doi: 10.18632/oncotarget.2501.
2 Proteolysis-inducing factor core peptide mediates dermcidin-induced proliferation of hepatic cells through multiple signalling networks.Int J Oncol. 2011 Sep;39(3):709-18. doi: 10.3892/ijo.2011.1064. Epub 2011 Jun 3.
3 Is there a human homologue to the murine proteolysis-inducing factor?.Clin Cancer Res. 2007 Sep 1;13(17):4984-92. doi: 10.1158/1078-0432.CCR-07-0946.
4 In vitro production of Spodoptera exigua multiple nucleopolyhedrovirus with enhanced insecticidal activity using a genotypically defined virus inoculum.J Biotechnol. 2017 Oct 10;259:19-25. doi: 10.1016/j.jbiotec.2017.08.001. Epub 2017 Aug 2.
5 Petite Integration Factor 1 (PIF1) helicase deficiency increases weight gain in Western diet-fed female mice without increased inflammatory markers or decreased glucose clearance.PLoS One. 2019 May 28;14(5):e0203101. doi: 10.1371/journal.pone.0203101. eCollection 2019.
6 Dermcidin expression confers a survival advantage in prostate cancer cells subjected to oxidative stress or hypoxia.Prostate. 2007 Sep 1;67(12):1308-17. doi: 10.1002/pros.20618.
7 The functions of the multi-tasking Pfh1(Pif1) helicase.Curr Genet. 2017 Aug;63(4):621-626. doi: 10.1007/s00294-016-0675-2. Epub 2017 Jan 4.
8 Genetic- and Lifestyle-dependent Dental Caries Defined by the Acidic Proline-rich Protein Genes PRH1 and PRH2.EBioMedicine. 2017 Dec;26:38-46. doi: 10.1016/j.ebiom.2017.11.019. Epub 2017 Nov 22.
9 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
10 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
11 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
12 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
13 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
14 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
15 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
16 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
17 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
18 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
19 A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo. Carcinogenesis. 2012 Jul;33(7):1421-9.
20 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
21 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
22 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
23 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
24 Petite Integration Factor 1 knockdown enhances gemcitabine sensitivity in pancreatic cancer cells via increasing DNA damage. J Appl Toxicol. 2023 Oct;43(10):1522-1532. doi: 10.1002/jat.4494. Epub 2023 May 16.